Quantitative high-throughput efficacy profiling of approved oncology drugs in inflammatory breast cancer models of acquired drug resistance and re-sensitization-Reference-Cited by-同舟云学术

Quantitative high-throughput efficacy profiling of approved oncology drugs in inflammatory breast cancer models of acquired drug resistance and re-sensitization

Published:2013-08 Issue:1 Volume:337 Page:77-89
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Williams Kevin P.,Allensworth Jennifer L.,Ingram Shalonda M.,Smith Ginger R.,Aldrich Amy J.,Sexton Jonathan Z.,Devi Gayathri R.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference60 articles.

1. Functional viability profiles of breast cancer;Brough;Cancer Discov.,2011

2. A systems analysis of the chemosensitivity of breast cancer cells to the polyamine analogue PG-11047;Kuo;BMC Med.,2009

3. Dissecting variability in responses to cancer chemotherapy through systems pharmacology;Yang;Clin. Pharmacol. Ther.,2010

4. Integrating complex genomic datasets and tumour cell sensitivity profiles to address a ’simple’ question: which patients should get this drug?;Benes;BMC Med.,2009

5. A strategy for predicting the chemosensitivity of human cancers and its application to drug discovery;Lee;Proc. Natl. Acad. Sci. USA,2007

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Altered ribosomal profile in acquired resistance and reversal associates with pathological response to chemotherapy in inflammatory breast cancer;npj Breast Cancer;2024-07-29

2. Novel Anti-Cancer Products Targeting AMPK: Natural Herbal Medicine against Breast Cancer;Molecules;2023-01-11

3. Adaptive stress response genes associated with breast cancer subtypes and survival outcomes reveal race-related differences;npj Breast Cancer;2022-06-13

4. Comparative transcriptional analyses of preclinical models and patient samples reveal MYC and RELA driven expression patterns that define the molecular landscape of IBC;npj Breast Cancer;2022-01-18

5. Dermal Lymphatic Invasion, Survival, and Time to Recurrence or Progression in Inflammatory Breast Cancer;American Journal of Clinical Oncology;2021-06-21